Ocugen expects $53.5M from stock sale amid efforts to bring Covaxin to the U.S. By: Philadelphia Business Journal via Business Journals February 24, 2022 at 13:09 PM EST Ocugen is continuing its efforts to bring a Covid-19 vaccine developed in India to the United States. Read More >>
